Patents
Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
07/2003
07/15/2003US6593327 Compounds and compositions as protease inhibitors
07/15/2003US6592894 Hydrogel-isolated cochleate formulations, process of preparation and their use for the delivery of biologically relevant molecules
07/10/2003WO2003055879A2 Tropane derivative, chelation product comprising this tropane derivative and a metal or a metal complex, and radiopharmaceutical
07/10/2003WO2003055858A1 Process for producing 1-alkoxycarbonyl nitrogenous saturated heterocyclic derivative
07/10/2003WO2003055850A1 β-AMYLOID PROTEIN PRODUCTION/SECRETION INHIBITORS
07/10/2003WO2003055478A1 Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders
07/10/2003WO2003043987A3 (4-phenyl) piperidin-3-yl-phenylcarboxylate derivatives and related compounds as beta-secretase inhibitors for the treatment of alzheimer's disease
07/10/2003WO2001098269A3 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
07/10/2003US20030130384 Flame retardant compositions
07/10/2003US20030130342 Such as anticoagulant 3-(6-(4-(aminoiminomethyl)phenyl methoxy)-2-methyl-2H-1-benzopyran-2-yl)propanoic acid hydrochloride
07/10/2003US20030130321 Method of resolving amlodipine racemate
07/10/2003US20030130320 Alpha 4 integrin antagonists
07/10/2003US20030130315 Administering a (R)-4-(1-hydroxy-4-(4-(hydroxydiphenyl methyl)-1-piperidinyl)butyl)-alpha,alpha-dimethyl-benzeneacetic acid derivative
07/10/2003US20030130313 Resolution in presence of reducing catalyst
07/10/2003US20030130312 Antiischemic agents; anticonvulsants; headaches
07/10/2003US20030130295 Substituted 2-aminoacetamides and the use thereof
07/10/2003US20030130287 Psychological disorders; central nervous system disorders; antidepressants; Parkinson's disease; Alzheimer's disease;cardiovascular disorders
07/10/2003US20030130272 Topoisomerase inhibitor; viricides
07/10/2003US20030130256 Stimulant of central nervous system regeneration
07/10/2003US20030130253 Central nervous system disorders; skin disorders; appetite suppressants
07/10/2003US20030130236 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs
07/10/2003US20030130204 Antipicornaviral compounds and compositons, their pharmaceutical uses, and materials for their synthesis
07/10/2003US20030130125 Pesticides; herbicides
07/10/2003US20030129134 Method of monitoring neuroprotective treatment
07/09/2003EP1325913A2 Piperidinecarboxylic acid amide derivatives
07/09/2003EP1325912A1 2,2-diphenylbutanamide derivatives and medicines containing the same
07/09/2003EP1324984A1 Butenolide and pentenolide derivatives as kinase inhibitors
07/09/2003EP1324970A2 Retinoids for the treatment of emphysema
07/09/2003CN1429229A Hydroxylamine esters as polymerization initiators
07/09/2003CN1429210A Substituted thioacetamides
07/09/2003CN1429200A Anthranyl amides and their use as medicaments
07/09/2003CN1428607A Method for detection or quantitative determination of metabolite of fentanyl or metabolite of fentanyl analogues and kit
07/09/2003CN1428334A Alkaloid compound, pain-stopping medicine and its preparation method
07/09/2003CN1113875C Substituted aromatic thiocarboxylic acid amides and their use as herbicides
07/09/2003CN1113867C Amino anthracyclinone derivatives and their use in treatment of amyloidosis
07/09/2003CN1113866C Process for preparation of piperidines
07/09/2003CN1113862C Arysulfonylamino hydroxamic acid derivs.
07/08/2003US6590121 Process for the preparation of 1,5-dideoxy-1,5-imino hexitols from oximes or imines
07/08/2003US6590115 Useful as ligands for metal catalysts for asymmetric reactions, in particular as rhodium complexes for asymmetric hydrogenation of enamide, itaconate, and alpha-ketoester compounds
07/08/2003US6590102 Process for producing piperidinecarbinols
07/08/2003US6589964 Method for enhancing mutant enzyme activities in lysosomal storage disorders
07/08/2003US6589956 Its enantiomers, diastereoisomers, and addition salts thereof with a pharmaceutically acceptable acid or base, and medicinal products containing the same which are useful as a TXA2 receptor antagonist and 5-HT2 receptor antagonist.
07/08/2003CA2280395C New hydroxamic acid derivatives, their preparation process and the pharmaceutical compositions which contain them
07/08/2003CA2264372C New benzocyclobutane compounds, their method of preparation, and pharmaceutical compositions containing them
07/03/2003WO2003054073A1 Novel flame retarding compounds
07/03/2003WO2003053994A1 Tetrahydrobenzfluorene derivatives
07/03/2003WO2003053942A1 Aryloxyphenyl and arylsulfanylphenyl derivatives
07/03/2003WO2003053931A1 Transition-metal-catalyzed process for the conversion of alkenes to sterically hindered substituted n-alkoxyamines
07/03/2003WO2003053930A1 1,4-dihydro-1,4-diphenylpyridine derivatives
07/03/2003WO2003053929A1 Process for production of optically active cis-piperidine derivatives
07/03/2003WO2003053928A1 Serotonine reuptake inhibitor
07/03/2003WO2003053919A1 Substituted cyclohexane derivatives
07/03/2003WO2003053912A1 α-(N-SULPHONAMIDO)ACETAMIDE DERIVATIVES AS β-AMYLOID INHIBITORS
07/03/2003WO2003053326A2 Enantiomers of n-(2,6-dimethylphenyl)-1-propyl-2-piperidinocarboxamide; its pharmaceutical compositions and processes of making them
07/03/2003US20030125560 Treating an N-formyl paroxetine compound with a de-formylation agent selected from hydrochloric acid, acetic acid, formic acid, methane sulfonic acid, maleic acid, and tartaric acid forms a salt of paroxetine
07/03/2003US20030125555 Piperidine-N-oxy group containing compounds stabilizes white, dyed, dipped, unscented or scented candle wax against discolration and fading
07/03/2003US20030125354 Aromatic compounds containing urea or thiourea groups are useful for terating cytokine mediated diseases
07/03/2003US20030125340 3-(Amino-or aminoalkyl) pyridinone derivatives and their use for the treatment of HIV related diseases
07/03/2003US20030125324 Alpha 4 beta 1 integrin and CD49d/ CD29 (vla-4); antiinflammatory agents
07/03/2003US20030125304 Substituted amino ketone compounds
07/03/2003US20030121110 Novel 1,4-diamino-2-alkenylbenzene derivatives , and dyes containing these compounds
07/03/2003CA2470813A1 1,4-dihydro-1,4-diphenylpyridine derivatives
07/03/2003CA2468831A1 Transition-metal-catalyzed process for the conversion of alkenes to sterically hindered substituted n-alkoxyamines
07/03/2003CA2467118A1 Aryloxyphenyl and arylsulfanylphenyl derivatives
07/02/2003EP1323713A1 5-phenylbenzylamine compounds, process for their production and intermediates for their synthesis
07/02/2003EP1323712A1 Process for producing multiform crystal of donepezil hydrochloride
07/02/2003EP1323711A1 Novel phenylalanine derivatives
07/02/2003EP1322628A2 Substituted urea neuropeptide y y5 receptor antagonists
07/02/2003EP1322613A1 Spiroheterocyclic nitriles useful as reversible inhibitors of cysteine proteases
07/02/2003EP1322612A1 Substituted amino-aza-cycloalkanes useful against malaria
07/02/2003EP1322611A1 Chemical compounds
07/02/2003EP1322609A2 Highly enantiomerically pure lactam-substituted propanoic acid derivatives and their preparation
07/02/2003EP1322598A1 Nitroso diphenylamine derivatives
07/02/2003EP1322596A1 Zwitterionic tachykinin receptor antagonists
07/02/2003EP1218372B1 Novel heterocyclic compounds useful as reversible inhibitors of cysteine proteases
07/02/2003EP0991627B1 Pyrimidinone compounds, pharmaceutical compositions containing the compounds and the process for preparing the same
07/02/2003EP0944582B1 Ketobenzamides as calpain inhibitors
07/02/2003CN1427821A Method for producing cyclic lactams
07/02/2003CN1427818A Factor VIIA inhibitor (thio) urea derivatives, their preparation and their use
07/02/2003CN1427809A Nitroaromatic solubilizer for nitroxyls in aromatic solvents
07/01/2003US6586627 N-protected/N-substituted-beta-amino hydroxy sulfonates
07/01/2003US6586598 α, α-dibromo-α-chloro-acetophenones as synthons
07/01/2003US6586507 Hydroxy-substituted N-alkoxy hindered amines and compositions stabilized therewith
07/01/2003US6586431 3,3-Biarylpiperidine and 2,2-biarylmorpholine derivatives
07/01/2003US6586430 Administering azabicyclo compounds to treat human immunodeficiency virus infections and respiratory system disorders
06/2003
06/26/2003WO2003051871A1 N-aroyl cyclic amine derivatives and their use as orxin receptor antagonist
06/26/2003WO2003051842A2 Compositions decreasing activity of hormone-sensitive lipase
06/26/2003WO2003051841A2 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
06/26/2003WO2003051840A1 Pyrrolidine and piperidine derivates as nk1 antagonists
06/26/2003WO2003051839A1 Novel compounds
06/26/2003WO2003051825A1 Human adam-10 inhibitors
06/26/2003WO2003051819A1 Substituted 1,5-diaminopentan-3-ol compounds
06/26/2003WO2003051276A2 Therapeutic heterocycles
06/26/2003US20030120077 Alkoxy substituted derivatives of 2,2,6,6-tetraalkyl-piperidines; oxidation-/heat-/actinic radiation- resistant coatings for automobiles
06/26/2003US20030120070 Serotonin 5-HT1A and dopamin D2 receptor ligands
06/26/2003US20030120034 N-(2-hydroxyethyl)-2,4,6-triiodo-5-(2-(2,4,6-triiodo-3-(N-meth yl acetamido)-5-(methylcarbamyl)benzamidoacetamido)-isophthalmic acid, derivatives
06/26/2003US20030119902 Novel aminobenzoephenones
06/26/2003US20030119883 Crystalline material
06/26/2003US20030119878 A 1-arylalkyl-3-aminoalkyl-1,4-dihydropyrid-4-one derivative; sexual disorders; anticarcinogenic agents; benign prostatic hypertrophy/fibroids of the uterus; endometriosis, polycystic ovarian disease, precocious puberty; contraceptives
06/26/2003US20030119874 Method for enhancing mutant enzyme activity in gaucher disease